The insurance company American International Group (AIG), which "vowed to temper spending after hosting a confe

"Documents and emails released this week ... suggest Pfizer's marketers influenced" research on the drug Neurontin "by declining to release or altering the conclusions of studies that found no beneficial effect from Neurontin for various off-label conditions," reports Keith Winstein.

The British "country brand capital development" firm Acanchi is crafting a "new image" for Israel. "Our research shows that Israel's brand is essentially the [Israel-Palestine] conflict," explained Israeli Foreign Ministry official Ido Aharoni.